European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. While the data was based on responses from 292 manufacturers across all sectors, the outcomes are applicable to pharmaceutical manufacturing. Meath opened last month.

Pharmaceutical manufacturing 104

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 104

European Pharmaceutical Review

JULY 25, 2022

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. This means falsified medicines may contain the wrong ingredients or low levels of the active ingredient – a terrifying prospect for a global consumer base reliant on medical treatments.

Pharmaceutical 104

Pharmaceutical Medicine Manufacturing Pharmaceutical manufacturing 104

Pharmaceutical Technology

SEPTEMBER 13, 2022

On closing of the deal, the results of PharmaLex will be included as a component within the International Healthcare Solutions sector of AmerisourceBergen. The PharmaLex takeover will build upon the current European presence of AmerisourceBergen in pharmaceutical supply and biopharma manufacturer services expertise.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Marketing 52

Medico Reach

FEBRUARY 8, 2023

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. billion by 2027.

Pharma 52

Pharma Medicine Marketing Prospecting 52

PM360

AUGUST 26, 2024

Unlike the “un”targeted approaches that are often associated on the trial-and-error method, an expanded definition of precision medicine, with a smarter and more integrated tool set, will enable healthcare professionals (HCPs) to try the optimal therapeutic approach… the first time. Bright Spots.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Pharmaceutical Technology

DECEMBER 19, 2022

Getting funding is going to be more difficult,” says Kyle Faget, partner and co-chair of Foley & Lardner’s Healthcare and Life Sciences Practices, Boston, Massachusetts. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Pharmaceutical 69

Pharmaceutical Manufacturing Medicine Government 69